This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on PrivateEquity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting privateequity investments in health care.
Privateequity investment in the health care sector continues to be a significant area of focus for the U.S. On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of privateequity investment in health care markets” (the FTC workshop). antitrust agencies.
Earlier this week, the Department of Justice (“DOJ”) and Federal Trade Commission (“FTC”) released the long-awaited 2023 Merger Guidelines. The final guidelines are the result of nearly two years of behind-the-scenes drafting, numerous public listening sessions and workshops, and the receipt of some 35,000 public comments.
As Holland & Knight observed previously, the Biden Administration's antitrust enforcers have trained their sights on privateequity firms and their portfolio companies, including in a Sept. 21, 2023, lawsuit challenging one privateequity firm's "roll-up" of anesthesiology practices in Texas.
As part of the Biden administration’s State of the Union blitz, the Federal Trade Commission (FTC) convened a workshop on privateequity (PE) investments in the health care industry on March 5, 2024.
PrivateEquity (PE) has been a popular and frequent target of the Biden Administration’s recent antitrust enforcement efforts. Earlier this year, the Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ) held workshops focusing on PE’s role in health care. By: Stinson LLP
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content